Menopause and hormone therapy in 2026.

Few areas of medicine have been as shaped — and as distorted — by the misreading of a single study as menopausal hormone therapy.

How the confusion happened

Early-2000s findings were widely reported in a way that left a generation of women, and clinicians, wary of hormone therapy altogether. Subsequent analysis painted a far more nuanced picture, particularly around the age at which therapy begins and the formulations used. But the cautious headline outlived the correction.

Where things stand now

The contemporary understanding is that menopausal hormone therapy can be an appropriate, beneficial choice for many women — especially when started closer to the menopausal transition — and that the risk-benefit balance depends on individual factors: age, time since menopause, personal and family history, and the specific therapy. It is a decision to be made carefully and individually, not foreclosed by a decades-old headline.

The honest framing

This is not a recommendation for or against therapy. It is a statement that women deserve an accurate, current, individualized conversation — one many have been denied. Menopausal symptoms are real and can be substantial, and there are real options to weigh.